Clinically proven probiotics are, for the most part, not available in the developing world and certainly not affordable for the majority of people. This is unconscionable considering these products can alleviate diarrhoea and various infections, which are by far the major cause of death in children and in adults who are HIV positive. Indeed, some of these products have been proven in developing world settings. Distribution networks exist along with pharmacies and clinics that dispense drugs and products that require refrigeration. So, are lack of profit or company resources the problem? Our university has shown that alternative community based kitchen models that produce probiotics can be established. These empower local people, are socially responsible, produce affordable products and deliver benefits to over 3,000 children and adults daily. Surely, other institutions and corporations can multiply this effect and develop social business models across the developing world that are supported by clinical and basic science studies? In this review, we will discuss the application of probiotics and selected nutrients in the first 1000 days of life, a critical timepoint which is particularly challenging in resource disadvantaged countries.

New titles

Related titles:

< >

Issue Details

Beneficial Microbes


Beneficial Microbes

Publication Cover
Print ISSN: 1876-2883
Online ISSN: 1876-2891
Get Permission

Journal Impact Factor Beneficial Microbes: 5.050

2021 CiteScore

Institutional Offers

For institutional orders, please contact sales@wageningenacademic.com.

Purchase Options

Individual Offers

Institutional Offers